BD (Becton, Dickinson and Company), a leading global medical technology company, has announced plans to invest more than $35m and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, Neb. facility to increase the resiliency of the U.S. health care system. The investments will support new BD® PosiFlush™ Prefilled Flush Syringe production lines, product…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
